跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Therabloc
Approved
STANDARD
Therabloc
Amherst Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8132b4f8a6e6dcc1
Company
Amherst Laboratories Inc.
Type
Standard
Approval Details
Approval Id
8132b4f8a6e6dcc1
Drug Approval Philippines Name
Therabloc
Product Name
Therabloc
Registration Number
DR-XY30586
Brand Name
Therabloc
Generic Name
Atenolol
Dosage Form
Tablet
Dosage Strength
100 mg
Manufacturer
Amherst Laboratories Inc.
Trader
UNILAB, Inc.
Issuance Date
28 September 2022
Expiry Date
27 November 2027
Pharmacologic Category
Selective Beta Blocking Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8132b4f8a6e6dcc1
Type
Standard
Back to Philippines FDA Approvals
Therabloc - Philippines FDA Drug Approval Details